SUMMARY One of the causes of anaemia in rheumatoid arthritis is thought to be defective iron absorption. In this study the 59Fe absorption in patients with active rheumatoid arthritis is measured and correlated with the results for bone marrow iron stores (and in some cases with the iron stores in the terminal duodenum), which were assessed simultaneously with semiquantitative methods, and with the serum ferritin concentration. In 11 patients with rheumatoid arthritis and increased bone marrow iron stores, iron absorption was decreased. In five patients it was normal and in three further patients, whose bone marrow iron stores were depleted, iron absorption was maximally increased. According to the results both intestinal malabsorption and defective iron absorption can be excluded as causes.
One of the most common extra-articular features of active rheumatoid arthritis (RA) is anaemia, which is generally normocytic, normochromic, and at times slightly hypochromic. Its pathogenesis is complex and by no means clear.' 2 In addition, depending on the index of activity, patients with RA show a decreased serum iron concentration, decreased serum transferrin, and increased serum ferritin. Serum ferritin generally yields higher than normal baseline values in patients suffering from RA.3 Abnormal ferrokinetic parameters and heterotopic quantitative iron stores have been demonstrated in synovial tissue8 and lymph nodes. 9 To what extent 'defective' iron absorption is causally related to the anaemia, the altered iron status, and the heterotopic pattern of iron stores associated with RA has been studied by various authors. 10 The studies published to date, however, are either based on indirect or semiquantitative methods11 12 appear to be inconclusive.13 14 Their results do not agree.
We have therefore measured whole body 59Fe retention in 19 patients suffering from RA with varying bone marrow iron stores.
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iron absorption was maximally increased to 94 (5-7)% (Table 1 and Fig. 1 ).
In group B (Table 1 ) the patients had a normal red blood count, normal serum ferritin values, and normal to slightly raised bone marrow iron stores. In these patients normal iron absorption rates were accordingly measured. A significant difference in this parameter was found between groups A and B (p=O-OOOl).
In some patients in groups A, B, and C (Table 1) and in all patients in the group ID gastroduodenoscopy was performed for diagnostic purposes.
Biopsies of three patients in group A (increased bone marrow iron stores) indicated the presence of large amounts of iron positive material in the duodenal villi. Otherwise this was found only in two patients with an iron overload due to transfusions. In two patients from each of the groups B and C and in all controls with iron deficiency anaemia (group ID) no iron could be demonstrated in the duodenal villi.
PAE of 59Fe was higher in group A (mean (SD)=29 (13.3)%) than in groups B and C (Table 1) . Thus in group A a considerable amount of temporarily retained iron must have been actively eliminated, whereas this did not occur in patients with RA who also had deficient bone marrow iron stores and in patients with simple iron deficiency anaemia (groups C and ID, both mean PAE=2%). Our patients with an iron overload due to transfusions had a PAE of 31%; this corresponds to the mean PAE of group A (29 (13-3)%, Table 1 ).
Radioiron absorption of our normal controls (group NC) with a mean (SD) of 29 (7- Fig. 1) show that active RA is not accompanied by a defect in iron absorp-tion, nor is such a defect responsible for the anaemia that is often associated with the disease. On the contrary, even in active RA there is an effective Fe absorption mechanism that compensates for iron deficiency by increasing the absorption rate. In cases of iron surplus, which is reliably reflected by the amount of iron confined to bone marrow macrophages, iron retention becomes protectively depressed. Accordingly patients with RA in group B fall within the 14 day iron retention normal range because during remission the anaemia is compensated for by use of the previously increased bone marrow iron stores (group B: mean (SD) 25 (6-1)%). From our results we infer that the degree of depression of iron absorption is related to the degree of severity of the anaemia in the patients with RA as long as the anaemia is exclusively related to the inflammatory process. This is always the case when utilisable iron is available in the bone marrow. If there is a negative iron balance, and if this is reflected as a depletion of iron stores, the organism adjusts iron absorption upwards to the highest physiologically possible degree, even during active disease.
The way the organism adjusts intestinal iron absorption rate to homoeostatic requirements is not completely understood.14 Nevertheless, convincing positive correlation can be established between body iron stores and histochemically assessed iron content of mucosal macrophages in the upper intestine, which favours the assumption that both iron compartments are connected in parallel. Thus the absorptive gut would be informed about actual iron requirements of the body and measurable postabsorption excretion of ingested iron would gain a morphological basis.
The (group C) owing to the use of non-steroidal drugs. The amount of drug induced blood loss, however, assessed by the 5tCr method hardly exceeds 3 ml a day,3( which represents the detection limit of whole body counting over short time intervals.'8 Thus our PAE data evaluated between day 7 and day 14 postabsorption would not be affected. 
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